Published Paper Details:

A novel human corona virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), was identified in China in December 2019. On January 30, 2020 the World Health Organization declared the outbreak of Public Health Emergency of International Concern due to increasing concerns over its fast spread. Vaccines represent the key weapon in fighting against COVID-19 for saving life's and ending this pandemic. Vaccines help human bodies to develop immunity againstCOVID-19. The vaccines that have been approved for emergency public use include COVAXIN, COVISHIELD, SPUTNIK-V. This vaccine provides the immunity against COVID19 by identifying it quickly and fight against it .It's common to experience some mild to moderate side effects when receiving vaccinations this is because your immune system instructs your body to react in certain ways. Some of the common side effects include pain, redness, swelling at the site of injection and tiredness, headache, muscle pain, chills, fever. Some of the rare symptoms like anaphylaxis, thrombosis with thrombocytopenia syndrome, Gillian Barre Syndrome, myocarditis and pericarditis. The aim of present study was Experimental survey on COVID-19vaccines by performing bleeding time and clotting time on vaccinated vs non vaccinated 300 volunteers (subjects).After observing the results we conclude that that the bleeding and clotting time values of vaccinated volunteers shows minimum range when compared to the non-vaccinated volunteers The two-tailed P value is less than 0.0001 by conventional criteria, this difference is considered to be extremely statistically significant. Finally the results showed that thrombosis is not a major adverse event for covid-19 vaccines.